SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Lind Lars) "

Sökning: WFRF:(Lind Lars)

  • Resultat 1-10 av 1453
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  • Dumanski, Jan P., et al. (författare)
  • Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease
  • 2016
  • Ingår i: American Journal of Human Genetics. - : Elsevier BV. - 0002-9297 .- 1537-6605. ; 98:6, s. 1208-1219
  • Tidskriftsartikel (refereegranskat)abstract
    • Men have a shorter life expectancy compared with women but the underlying factor(s) are not clear. Late-onset, sporadic Alzheimer disease (AD) is a common and lethal neurodegenerative disorder and many germline inherited variants have been found to influence the risk of developing AD. Our previous results show that a fundamentally different genetic variant, i.e., lifetime-acquired loss of chromosome Y (LOY) in blood cells, is associated with all-cause mortality and an increased risk of non-hematological tumors and that LOY could be induced by tobacco smoking. We tested here a hypothesis that men with LOY are more susceptible to AD and show that LOY is associated with AD in three independent studies of different types. In a case-control study, males with AD diagnosis had higher degree of LOY mosaicism (adjusted odds ratio = 2.80, p = 0.0184, AD events = 606). Furthermore, in two prospective studies, men with LOY at blood sampling had greater risk for incident AD diagnosis during follow-up time (hazard ratio [HR] = 6.80, 95% confidence interval [95% CI] = 2.16-21.43, AD events = 140, p = 0.0011). Thus, LOY in blood is associated with risks of both AD and cancer, suggesting a role of LOY in blood cells on disease processes in other tissues, possibly via defective immunosurveillance. As a male-specific risk factor, LOY might explain why males on average live shorter lives than females.
  •  
5.
  •  
6.
  • Dumanski, Jan P., et al. (författare)
  • Smoking is associated with mosaic loss of chromosome Y
  • 2015
  • Ingår i: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 347:6217, s. 81-83
  • Tidskriftsartikel (refereegranskat)abstract
    • Tobacco smoking is a risk factor for numerous disorders, including cancers affecting organs outside the respiratory tract. Epidemiological data suggest that smoking is a greater risk factor for these cancers in males compared to females. This observation, together with the fact that males have a higher incidence of and mortality from most non-sex-specific cancers, remains unexplained. Loss of chromosome Y (LOY) in blood cells is associated with increased risk of nonhematological tumors. We demonstrate here that smoking is associated with LOY in blood cells in three independent cohorts [TwinGene: odds ratio (OR) = 4.3, 95% CI = 2.8-6.7; ULSAM: OR = 2.4, 95% CI = 1.6-3.6; and PIVUS: OR = 3.5, 95% CI = 1.4-8.4] encompassing a total of 6014 men. The data also suggest that smoking has a transient and dose-dependent mutagenic effect on LOY status. The finding that smoking induces LOY thus links a preventable risk factor with the most common acquired human mutation.
  •  
7.
  • Eriksson, Jan W., et al. (författare)
  • Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation : the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study
  • 2008
  • Ingår i: Hypertension. - : American Heart Association. - 0194-911X .- 1524-4563. ; 52:6, s. 1030-1037
  • Tidskriftsartikel (refereegranskat)abstract
    • Treatment with angiotensin II receptor blockers is associated with lower risk for the development of type 2 diabetes mellitus compared with thiazide diuretics. The Mechanisms for the Diabetes Preventing Effect of Candesartan Study addressed insulin action and secretion and body fat distribution after treatment with candesartan, hydrochlorothiazide, and placebo. Twenty-six nondiabetic, abdominally obese, hypertensive patients were included in a multicenter 3-way crossover trial, and 22 completers (by predefined criteria; 10 men and 12 women) were included in the analyses. They underwent 12-week treatment periods with candesartan (C; 16 to 32 mg), hydrochlorothiazide (H; 25 to 50 mg), and placebo (P), respectively, and the treatment order was randomly assigned and double blinded. Intravenous glucose tolerance tests and euglycemic hyperinsulinemic (56 mU/m(2) per minute) clamps were performed. Intrahepatic and intramyocellular and extramyocellular lipid content and subcutaneous and visceral abdominal adipose tissue were measured using proton magnetic resonance spectroscopy and MRI. Insulin sensitivity (M-value) was reduced following H versus C and P (6.07+/-2.05, 6.63+/-2.04, and 6.90+/-2.10 mg/kg of body weight per minute, mean+/-SD; P
  •  
8.
  • Ferreira, Daniel, et al. (författare)
  • The interactive effect of demographic and clinical factors on hippocampal volume : A multicohort study on 1958 cognitively normal individuals
  • 2017
  • Ingår i: Hippocampus. - : Wiley. - 1050-9631 .- 1098-1063. ; 27:6, s. 653-667
  • Tidskriftsartikel (refereegranskat)abstract
    • Alzheimer's disease is characterized by hippocampal atrophy. Other factors also influence the hippocampal volume, but their interactive effect has not been investigated before in cognitively healthy individuals. The aim of this study is to evaluate the interactive effect of key demographic and clinical factors on hippocampal volume, in contrast to previous studies frequently investigating these factors in a separate manner. Also, to investigate how comparable the control groups from ADNI, AIBL, and AddNeuroMed are with five population-based cohorts. In this study, 1958 participants were included (100 AddNeuroMed, 226 ADNI, 155 AIBL, 59 BRC, 295 GENIC, 279 BioFiNDER, 398 PIVUS, and 446 SNAC-K). ANOVA and random forest were used for testing between-cohort differences in demographic-clinical variables. Multiple regression was used to study the influence of demographic-clinical variables on hippocampal volume. ANCOVA was used to analyze whether between-cohort differences in demographic-clinical variables explained between-cohort differences in hippocampal volume. Age and global brain atrophy were the most important variables in explaining variability in hippocampal volume. These variables were not only important themselves but also in interaction with gender, education, MMSE, and total intracranial volume. AddNeuroMed, ADNI, and AIBL differed from the population-based cohorts in several demographic-clinical variables that had a significant effect on hippocampal volume. Variability in hippocampal volume in individuals with normal cognition is high. Differences that previously tended to be related to disease mechanisms could also be partly explained by demographic and clinical factors independent from the disease. Furthermore, cognitively normal individuals especially from ADNI and AIBL are not representative of the general population. These findings may have important implications for future research and clinical trials, translating imaging biomarkers to the general population, and validating current diagnostic criteria for Alzheimer's disease and predementia stages.
  •  
9.
  • Forsberg, Lars A., 1974-, et al. (författare)
  • Mosaic loss of chromosome Y in leukocytes matters
  • 2019
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 51:1, s. 4-7
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
10.
  • Forsberg, Lars A., et al. (författare)
  • Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer
  • 2014
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 46:6, s. 624-628
  • Tidskriftsartikel (refereegranskat)abstract
    • Incidence and mortality for sex-unspecific cancers are higher among men, a fact that is largely unexplained(1,2). Furthermore, age-related loss of chromosome Y (LOY) is frequent in normal hematopoietic cells(3,4), but the phenotypic consequences of LOY have been elusive(5-10). From analysis of 1,153 elderly men, we report that LOY in peripheral blood was associated with risks of all-cause mortality (hazards ratio (HR) = 1.91, 95% confidence interval (CI) = 1.17-3.13; 637 events) and non-hematological cancer mortality (HR = 3.62, 95% CI = 1.56-8.41; 132 events). LOY affected at least 8.2% of the subjects in this cohort, and median survival times among men with LOY were 5.5 years shorter. Association of LOY with risk of all-cause mortality was validated in an independent cohort (HR = 3.66) in which 20.5% of subjects showed LOY. These results illustrate the impact of post-zygotic mosaicism on disease risk, could explain why males are more frequently affected by cancer and suggest that chromosome Y is important in processes beyond sex determination. LOY in blood could become a predictive biomarker of male carcinogenesis.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 1453
Typ av publikation
tidskriftsartikel (1228)
konferensbidrag (109)
annan publikation (41)
doktorsavhandling (33)
bokkapitel (16)
rapport (9)
visa fler...
forskningsöversikt (9)
samlingsverk (redaktörskap) (3)
licentiatavhandling (3)
bok (2)
visa färre...
Typ av innehåll
refereegranskat (1257)
övrigt vetenskapligt/konstnärligt (178)
populärvet., debatt m.m. (14)
Författare/redaktör
Lind, Lars (993)
Ingelsson, Erik (161)
Wernersson, Lars-Eri ... (150)
Lind, Erik (150)
Sundström, Johan (143)
Ärnlöv, Johan (101)
visa fler...
Larsson, Anders (95)
Johansson, Lars (85)
Ärnlöv, Johan, 1970- (81)
Sundström, Johan, Pr ... (70)
Gustafsson, Stefan (70)
Morris, Andrew P. (70)
Ingelsson, Erik, 197 ... (70)
Ahlström, Håkan (63)
Lind, L (54)
Mahajan, Anubha (53)
Lindgren, Cecilia M. (53)
Engström, Gunnar (52)
Lithell, Hans (50)
Fall, Tove, 1979- (49)
Melhus, Håkan (47)
Giedraitis, Vilmanta ... (47)
Wareham, Nicholas J. (46)
Langenberg, Claudia (46)
Salomaa, Veikko (45)
Laakso, Markku (44)
Lind, P. Monica (42)
Salihovic, Samira, 1 ... (42)
Elmståhl, Sölve (41)
Zethelius, Björn (41)
Gieger, Christian (41)
Brodin, Lars-Åke (41)
Syvänen, Ann-Christi ... (39)
McCarthy, Mark I (39)
Boehnke, Michael (39)
Groop, Leif (38)
Melander, Olle (38)
Loos, Ruth J F (38)
Hayward, Caroline (38)
Gudnason, Vilmundur (38)
Tuomilehto, Jaakko (37)
Luan, Jian'an (37)
Risérus, Ulf (36)
Ohkubo, Takayoshi (36)
Lind, P. Monica, 195 ... (36)
Uitterlinden, André ... (36)
van Bavel, Bert, 196 ... (36)
Berne, Christian (35)
Mohlke, Karen L (35)
Esko, Tonu (35)
visa färre...
Lärosäte
Uppsala universitet (935)
Lunds universitet (281)
Karolinska Institutet (239)
Umeå universitet (127)
Örebro universitet (97)
Högskolan Dalarna (94)
visa fler...
Göteborgs universitet (72)
Kungliga Tekniska Högskolan (66)
Linköpings universitet (33)
Chalmers tekniska högskola (20)
Stockholms universitet (17)
Högskolan i Gävle (15)
Högskolan i Skövde (11)
Jönköping University (10)
Högskolan i Borås (6)
Gymnastik- och idrottshögskolan (5)
Högskolan Kristianstad (3)
Mittuniversitetet (3)
Linnéuniversitetet (3)
Sveriges Lantbruksuniversitet (3)
Luleå tekniska universitet (2)
Malmö universitet (2)
Södertörns högskola (2)
Högskolan i Halmstad (1)
Högskolan Väst (1)
Mälardalens universitet (1)
RISE (1)
Karlstads universitet (1)
Sophiahemmet Högskola (1)
Marie Cederschiöld högskola (1)
visa färre...
Språk
Engelska (1390)
Svenska (37)
Odefinierat språk (26)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (635)
Teknik (204)
Naturvetenskap (165)
Samhällsvetenskap (35)
Humaniora (12)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy